Abstract

In clinical practice to treat esophageal cancer, both photodynamic therapy (PDT) and argon plasma coagulation therapy (APC) are often used because they are less invasive than surgery and chemoradiotherapy. In japan, because PDT requires sophisticated equipment, its availability is limited to few hospitals. On the other hand, APC is more available than PDT. The selection criteria for esophageal cancer therapy has not been definitely established. For better therapeutic selection, we retrospectively investigated the efficacy and safety of PDT and APC in esophageal cancer.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call